SAN FRANCISCO (GenomeWeb) – NanoString highlighted the promise of its upcoming technologies as well as its progress in the oncology field at the JP Morgan Healthcare Conference held here this week.

With an eye on the future, CEO Brad Gray said the firm expects its upcoming Digital Spatial Profiling and Hyb & Seq technologies to make major dents in biology and the clinical sequencing markets.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more